--- title: "12 Health Care Stocks Moving In Friday's Pre-Market Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/286564951.md" description: "In Friday's pre-market session, HCW Biologics saw a significant gain of 211.6%, reaching $1.05, following its Q1 earnings report. Other gainers included P3 Health Partners (+21.33%), Intelligent Bio Solutions (+12.65%), and Lifeward (+11.75%). Conversely, Aardvark Therapeutics experienced a sharp decline of 41.8%, while Zentek and Claritev fell by 25.79% and 19.05%, respectively." datetime: "2026-05-15T12:06:29.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286564951.md) - [en](https://longbridge.com/en/news/286564951.md) - [zh-HK](https://longbridge.com/zh-HK/news/286564951.md) --- # 12 Health Care Stocks Moving In Friday's Pre-Market Session ### Gainers - **HCW Biologics** (NASDAQ:HCWB) stock increased by 211.6% to $1.05 during Friday's pre-market session. The market value of their outstanding shares is at $2.2 million. As per the news, the Q1 earnings report came out yesterday. - **P3 Health Partners** (NASDAQ:PIII) stock rose 21.33% to $4.89. The company's market cap stands at $13.2 million. As per the news, the Q1 earnings report came out yesterday. - **Intelligent Bio Solutions** (NASDAQ:INBS) stock increased by 12.65% to $4.63. The market value of their outstanding shares is at $8.9 million. The company's, Q3 earnings came out 2 days ago. - **Lifeward** (NASDAQ:LFWD) shares moved upwards by 11.75% to $7.37. The market value of their outstanding shares is at $18.3 million. The company's, Q1 earnings came out today. - **Sol-Gel Technologies** (NASDAQ:SLGL) stock rose 11.38% to $76.5. The market value of their outstanding shares is at $222.8 million. - **MiNK Therapeutics** (NASDAQ:INKT) shares rose 9.89% to $11.55. The company's market cap stands at $49.3 million. The company's, Q1 earnings came out today. ### Losers - **Aardvark Therapeutics** (NASDAQ:AARD) shares decreased by 41.8% to $3.92 during Friday's pre-market session. The market value of their outstanding shares is at $146.8 million. - **Zentek** (NASDAQ:ZTEK) stock declined by 25.79% to $0.75. The company's market cap stands at $108.6 million. - **Claritev** (NYSE:CTEV) stock declined by 19.05% to $19.0. The company's market cap stands at $400.1 million. - **WORK Medical Tech Gr** (NASDAQ:WOK) shares decreased by 17.72% to $1.07. - **Dare Bioscience** (NASDAQ:DARE) shares decreased by 14.69% to $2.44. The market value of their outstanding shares is at $41.6 million. As per the press release, Q1 earnings came out yesterday. - **Galmed Pharmaceuticals** (NASDAQ:GLMD) stock decreased by 13.43% to $0.57. The company's market cap stands at $4.3 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [HCWB.US](https://longbridge.com/en/quote/HCWB.US.md) - [PIII.US](https://longbridge.com/en/quote/PIII.US.md) - [AARD.US](https://longbridge.com/en/quote/AARD.US.md) - [ZTEK.US](https://longbridge.com/en/quote/ZTEK.US.md) - [INBS.US](https://longbridge.com/en/quote/INBS.US.md) - [LFWD.US](https://longbridge.com/en/quote/LFWD.US.md) - [CTEV.US](https://longbridge.com/en/quote/CTEV.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [SLGL.US](https://longbridge.com/en/quote/SLGL.US.md) - [INKT.US](https://longbridge.com/en/quote/INKT.US.md) - [WOK.US](https://longbridge.com/en/quote/WOK.US.md) - [DARE.US](https://longbridge.com/en/quote/DARE.US.md) - [GLMD.US](https://longbridge.com/en/quote/GLMD.US.md) - [PIIIW.US](https://longbridge.com/en/quote/PIIIW.US.md) - [MPLNW.US](https://longbridge.com/en/quote/MPLNW.US.md) ## Related News & Research - [Roth MKM Sticks to Their Buy Rating for Capricor Therapeutics (CAPR)](https://longbridge.com/en/news/286497683.md) - [Leerink Partners Sticks to Their Buy Rating for Ibio (IBIO)](https://longbridge.com/en/news/286588262.md) - [](https://longbridge.com/en/news/286580692.md) - [P3 Health Partners Q1 revenue rises 4%, adjusted EBITDA turns positive](https://longbridge.com/en/news/286461585.md) - [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md)